| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/22/2004 | US20040142869 Methods of use of recombinant vasoactive protein from salivary gland of the black fly |
| 07/22/2004 | US20040142866 Derivatives of the insulinotropic peptide exendin-4 and methods of production thereof |
| 07/22/2004 | US20040142865 methods for treating cancer patients with therapeutics that inhibit or degrade the OPN-b or OPN-c isoforms specifically, thereby leaving the innocuous OPN-a form intact and available to perform its normal functions in the cell |
| 07/22/2004 | US20040142862 Methods and compositions for modulating agonist-induced downregulation of G protein-coupled receptors |
| 07/22/2004 | US20040142861 at least one genetically-engineered growth factor, at least one genetically-engineered antioxidant, at least one genetically-engineered extracellular matrix component |
| 07/22/2004 | US20040142856 Glycoconjugation methods and proteins/peptides produced by the methods |
| 07/22/2004 | US20040142855 to facilitate allogeneic engraftment of donor cells and tissues in vivo with the resultant induction of donor-specific tolerance; can form a complex with the T cell receptor (TCR) beta chain, alone or in association with the CD3 antigen |
| 07/22/2004 | US20040142854 internalization sequence covalently linked to the modulating agent, a liposome that encapsulates the modulating agent or an antibody or ligand that binds to a cell surface receptor; alopecia |
| 07/22/2004 | US20040142494 for specifically binding particulates such as cells, especially bacterial cells or hematopoietic cells and a means for detecting the particulates specifically bound to a platform |
| 07/22/2004 | US20040142478 Expression vector comprising saccharomyces regulatory sequences for controlling heterologous and homologous gene expression; genetic engineering protein translation |
| 07/22/2004 | US20040142477 Expression vector comprising antisense or inhibitory RNA sequences for use in increasing phyotene concentration in plants; tissue engineering |
| 07/22/2004 | US20040142471 Preparing membrane receptors from extracellular baciloviruses |
| 07/22/2004 | US20040142455 Recombinant botulinum toxins having a soluble C-terminal portion of a heavy chain, an N-terminal portion of a heavy chain and a light chain |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142452 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 07/22/2004 | US20040142449 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 07/22/2004 | US20040142446 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 07/22/2004 | US20040142443 Comprises generating recombination polypeptide (RUVB) for use in controlling homologous recombination efficiency or transformation efficiency in plants |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142430 Production of a multimeric protein by cell fusion method |
| 07/22/2004 | US20040142429 Using nickel-chelate chromatography to purifiy and recover hydrophobic proteins, polypeptides or peptides in non-aggregated form; lipid bilayer formation |
| 07/22/2004 | US20040142428 Mammalian cytokine-like polypeptide-10 |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142423 Novel polypeptides, DNAs encoding the same and use thereof |
| 07/22/2004 | US20040142422 Cytokine receptor zcytor17 |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142420 Comprises nucleotide sequences coding cytokine for use as tool in identiying modulators for treatment of arthritis, inflammation and inflammatory bowel disease; gene therapy |
| 07/22/2004 | US20040142419 Reducing cellular dysfunction caused by mitochondrial gene mutations |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142417 Receptor proteins |
| 07/22/2004 | US20040142415 Comprises nucleotide sequences coding serum amyloid apolipoprotein-3 for use in treatment and prevent of enteric infections |
| 07/22/2004 | US20040142404 Designing cyclic peptide which modulates tyrosine kinase activity and can be used as potential treatment for asthma, eczema, food allergies, cancer, inflammatory bowel and autoimmune diseases; enzyme inhibitors |
| 07/22/2004 | US20040142399 Recombinant FlaA as a diagnostic reagent |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142391 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE |
| 07/22/2004 | US20040142390 Novel mammalian catecholamine receptor genes and uses |
| 07/22/2004 | US20040142389 Immunoglobulin which specifically binds gastrointestinal tract (GIT) transport receptors for use as tools in tissue targeted therapies; drug screening and delivery |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142374 PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use |
| 07/22/2004 | US20040142372 Comprises nucleotide sequences coding cytokine binding protein for use in identifying modulators for treatment of cell proliferative and inflammatory disorders |
| 07/22/2004 | US20040142367 breast cancer protein (BCMP 101) sequences as a target for breast cancer therapy and diagnosis |
| 07/22/2004 | US20040142364 Fungal transcriptional activator useful in methods for producing polypeptides |
| 07/22/2004 | US20040142361 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/22/2004 | US20040142357 Novel telomerase inhibitors and uses therefor |
| 07/22/2004 | US20040142355 Methods, compositions and libraries pertaining to PNA dimer and PNA oligomer synthesis |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 07/22/2004 | US20040142352 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142342 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions |
| 07/22/2004 | US20040142333 for diagnostics, biosensors, bioreactors, drug screening and therapy; genetic engineering |
| 07/22/2004 | US20040142332 Desaturase antigen of mycobacterium tuberculosis |
| 07/22/2004 | US20040142331 used to induce antibodies and drug screening; microarrays; solid phase synthesis; genetic engineering |
| 07/22/2004 | US20040142321 HCV assay |
| 07/22/2004 | US20040142320 use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome for diagnosis/drug screening; antibiotic resistance |
| 07/22/2004 | US20040142086 Method and apparatus for separation of milk, colostrum, and whey |
| 07/22/2004 | US20040142068 Method and apparatus for separation of milk, colostrum, and whey |
| 07/22/2004 | US20040142047 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 07/22/2004 | US20040142037 Lactoferrin compositions and methods of wound treatment |
| 07/22/2004 | US20040142003 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 07/22/2004 | US20040142002 Recombinant poxvirus |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141996 deglycosylated HIV proteins comprise at least one epitope region which does not elicit an immune response in man when encountered by infection or environmental exposure but does elicit an immune response in a non-human species. |
| 07/22/2004 | US20040141995 MHC class I-restricted and MHC class II-restricted EBNA1 peptides |
| 07/22/2004 | US20040141993 FAFSD target peptide or an anlogue covalently linked to a helper T cell epitope; reducing adherence to the urinary tract mucosa by type 1 fimbriated uropathogenic enterobacteriae to prevent urinary tract infection |
| 07/22/2004 | US20040141990 Metastic colorectal cancer vaccine |
| 07/22/2004 | US20040141989 polypeptides comprising segments of prostate gland proteins and to DNA codes for such polypeptides used in vaccines for prophylaxis of tumors |
| 07/22/2004 | US20040141988 Tumour-specific animal proteins |
| 07/22/2004 | US20040141987 vaccines against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/22/2004 | US20040141985 Biossay for measuring the release of interferons from lymphocytes; inoculation against infection by mycobacterium by administering CD8 epitopes capable of inhibiting the binding of the epitopes to lymphocyte receptors |
| 07/22/2004 | US20040141984 Amyloid beta 1-6 antigen arrays |
| 07/22/2004 | US20040141983 Compositions against cancer antigen LIV-1 and uses thereof |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141978 Angiogenesis related molecules |
| 07/22/2004 | US20040141977 the ATRX gene and/or its polypeptide product are anti-apoptopic, and provide a positive viability signal to the apoptotic pathway; methods for treating, diagnosing, prognosing apoptosis related diseases |
| 07/22/2004 | US20040141975 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 07/22/2004 | US20040141972 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141971 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141970 recombinant production of novel DNA and novel polypeptides the presence of which is associated with inflammatory diseases (inflammation associated antigens) and/or cancer; diagnosis and treatment of conditions characterized by such antigens |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141959 Somatic cells with ablated PrP gene and methods of use |
| 07/22/2004 | US20040141958 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte |
| 07/22/2004 | US20040141953 delivery of a neurotrophin to targeted defective, diseased or damaged cholinergic neurons |
| 07/22/2004 | US20040141952 Death domain containing receptor 5 |
| 07/22/2004 | US20040141948 high mobility group box protein (HMGB) A box or variant thereof which can inhibit release of a proinflammatory cytokine |
| 07/22/2004 | US20040141947 Method for treatment of demyelinating central nervous system disease |
| 07/22/2004 | US20040141939 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/22/2004 | US20040139864 Method and apparatus for separation of milk, colostrum, and whey |
| 07/22/2004 | DE10300649A1 Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von genetisch veränderten Organismen Process for the preparation of ketocarotenoids by cultivation of genetically modified organisms |
| 07/22/2004 | CA2515518A1 Irs modulators |
| 07/22/2004 | CA2512512A1 Uses of hmgb, hmgn, hmga proteins |
| 07/22/2004 | CA2512365A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof |
| 07/22/2004 | CA2512138A1 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | CA2512052A1 Human growth hormone crystals and methods for preparing them |
| 07/22/2004 | CA2511966A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 07/22/2004 | CA2511907A1 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | CA2511824A1 Cell proliferation-related polypeptides and uses therefor |
| 07/22/2004 | CA2511817A1 Novel compositions and methods in cancer |